CoreAge Rx
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
Henry Meds sits at No. 31 in our ranking with a Brief Score of 84. Here are the GLP-1 desks we'd weigh against it — ranked on the same six-factor Brief Score, top down.
Prefer a straight head-to-head? CoreAge Rx vs Henry Meds.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
A transparent, tiered compounding desk that lays out every price on the ladder up front — semaglutide, tirzepatide, microdose, and a combo line — with NAD+ care sitting alongside.
A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.
FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.
A polished, nationwide wellness brand at a premium price — but without a LegitScript badge to back the sticker.
Telehealth wellness clinic offering GLP-1 medications on a 4-week billing cycle.
A men's-only protocol shop with flat, disclosed GLP-1 pricing, a named Chief Medical Advisor, and a named 503A compounding pharmacy — rare transparency for this tier of the ranking.
WePeptideRx is a provider-guided telehealth platform offering compounded semaglutide and tirzepatide alongside a deep menu of peptide, hormone, hair, and sexual-wellness programs.
Fully online compounded GLP-1 telehealth offering semaglutide and tirzepatide injections from FDA-regulated 503A and 503B compounding pharmacies.
Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.
Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.